How weight-loss injections are turning obesity into a wealth issue

Thousands of NHS patients are believed to be missing out. And with the NHS tightly restricting access, some working in the field warn a two-tier system around weight-loss drugs is developing - one that's benefitting the most well-off. Martin Fidock, who is UK managing director of Ovivia, which provi...

Redirecting to full article...